首页> 外文期刊>Materials Chemistry Frontiers >Biologically-derived nanoparticles for chemo-ferroptosis combination therapy
【24h】

Biologically-derived nanoparticles for chemo-ferroptosis combination therapy

机译:源自生物纳米粒子的chemo-ferroptosis联合治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Biologically-derived nanoparticles (NPs) are an emerging type of drug carrier in the field of biomedicine due to their unique biological and physicochemical properties. However, the preparation of biologically-derived NPs often requires complex procedures and/or organic solvents, which may reduce versatility in amenable functionalization strategies and suitability for potential biological applications. Herein, we report a green and facile strategy for the scalable synthesis of biologically-derived NPs from mung beans (MBs) and demonstrate an example application in combination cancer therapy. The MB NPs (MBNs) are mainly composed of proteins, polysaccharides, polyphenols, and flavonoids. Doxorubicin (DOX) and metal ions (i.e., Fe~(2+)) can be easily loaded into MBNs, which show their potential as agents for chemo-ferroptosis combination therapy and magnetic resonance imaging. The study establishes a promising strategy to engineer functional NPs of potential interest for biomedical applications including bio-imaging and therapeutic delivery.
机译:是一个源自生物纳米粒子(NPs)新兴领域的药物载体的类型由于其独特的生物学和生物医学物理化学性质。制备生物衍生NPs经常需要复杂的程序和/或有机溶剂,可以减少多功能性的功能化策略和适合潜在的生物应用程序。简单的可伸缩的合成策略从绿豆源自生物的NPs (MBs)演示了一个示例应用程序癌症治疗结合。主要由蛋白质、多糖、多酚和类黄酮。和金属离子(例如,Fe ~(2 +))可以很容易地加载到拥有,这显示他们的潜力代理chemo-ferroptosis联合治疗和磁共振成像。建立一个有前途的战略工程师功能性NPs的潜在利益包括能和生物医学应用治疗交付。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号